There is a turbulent route in the world of breast health where emotions interconnect with uncertainty, creating feelings of uncertainty and anxiety. In this setting, proliferative breast disease with atypia (PBDA) develops as a frightening presence that weighs heavily on the minds of those it affects.
PBDA is a rapid increase in cells in the breast ducts or lobules and may show some unusual characteristics under a microscope. These abnormal characteristics show significant deviation from typical cell structure and function, raising questions regarding the possibility of breast cancer growth.
“Atypical hyperplasia (or atypia) describes abnormal cell modifications that frequently point to precancerous or cancerous diseases. This is because of abnormal variations in cell size, shape, and organization. It calls for more research because of how important it is in pathological analyses,” explains Dr. Garvit Chitkara, a breast cancer surgeon in Mumbai.
In this space, we explore the nuances, challenges, and triumphs accompanying the complex condition of proliferative breast disease with atypia.
Proliferative breast disease with atypia is divided into the following subgroups based on the precise site of abnormal cell growth:
Atypical ductal hyperplasia (ADH) is a condition in which the breast’s ducts experience abnormal cell proliferation.
Atypical lobular hyperplasia (ALH) is a condition that causes aberrant cell growth in the breast’s lobules.
“Both ADH and ALH are conditions regarded as a marker for an increased chance of developing breast cancer,” says renowned breast oncology surgeon in Mumbai, Dr. Garvit Chitkara.
Although atypical hyperplasia falls under the umbrella of benign breast conditions, it is considered a higher-risk category for cancer. The precise degree of the risk can vary depending on several factors, including the type of atypia, age, a family history of breast cancer, and other personal risk factors.
Years of research have demonstrated that a woman’s later risk of developing breast cancer increases with her age at the time of her atypical hyperplasia diagnosis.
“Proliferative breast disease with atypia is typically diagnosed with a biopsy, a procedure where a sample of breast tissue is taken and evaluated by a pathologist,” says highly-skilled surgical oncologist Dr. Garvit Chitkara.
With over a decade of expertise in breast oncology, Dr. Chitkara is often called the best breast surgeon in Mumbai.
Clinical examination, imaging techniques, and histological evaluation of breast tissue samples are commonly used to diagnose proliferative breast lesion with atypia. The general steps in the diagnosis are as follows:
A medical professional may physically examine the breasts to look for any palpable lumps, modifications to the breast’s shape or texture, or other anomalies. The doctor may also discuss the patient’s medical history and risk factors.
Mammography is frequently performed to find areas of calcification or masses in the breast. In some circumstances, further imaging methods like ultrasound or magnetic resonance imaging (MRI) may be advised to further assess the breast tissue.
A biopsy is often carried out to take a sample of breast tissue for further analysis if an abnormality is seen on imaging or if there are clinical concerns. The type of biopsy (needle or surgical) employed depends on the particular circumstance and the size/location of the abnormality.
The biopsy sample is examined by a pathologist under a microscope to evaluate the cellular and architectural characteristics of the breast tissue. If atypia is seen, the pathologist will assess the degree of atypia and identify the exact type (for example, atypical ductal hyperplasia, or atypical lobular hyperplasia).
“Regular health checkups are crucial to leading a healthy life,” advises Dr. Garvit Chitkara. “Early diagnosis can help you to take prompt actions to treat and manage any health condition.”
Proliferative breast disease with atypia treatment usually involves the surgical removal of the area where atypical cells were found through a lumpectomy or excisional biopsy and recently
Vaccum assisted breast biopsy (VABB) has also been added to the armamentarium of breast biopsy techniques. This is done to both establish a definitive diagnosis and reduce the risk of potential progression to breast cancer.
After surgery, close monitoring and increased screening are typically advised to detect any potential recurrence or development of breast cancer. This may include regular clinical breast exams every six months and annual mammograms. Some patients, based on their individual risk factors, may also be recommended to undergo additional screening, such as high-risk screening annual MRI scans, alternating with mammograms. Breast MRI can be particularly beneficial for women with dense breast tissue.
“Women can also have proliferative breast disease without atypia, a condition that does not exhibit the abnormal cellular features seen in atypical hyperplasia,” adds Dr. Garvit Chitkara. “Proliferative breast disease without atypia treatment and management includes regular monitoring, risk assessment, and lifestyle modifications.”
Dr. Garvit Chitkara is among the leading oncologists for people seeking breast cancer surgery in Mumbai.
Most people with proliferative breast disease with atypia do not develop breast cancer, despite their risk being higher than that of the general population. However, diligent observation and follow-up care are necessary to find any changes or potential advancement.
Regular breast checks, imaging tests (such as mammography or breast MRI), and consultations with healthcare professionals to identify an individualized approach are all possible management techniques. Depending on the unique conditions, possible treatments may include surgery or medication.
If you are concerned about the implications of Proliferative breast disease with atypia, please speak with a cancer specialist like Dr. Garvit Chitkara. He will work with you to create a custom care plan based on your unique risk factors and medical background.